Coronary revascularization in patients with stable coronary disease and diabetes mellitus.
Salman Zahoor BhatYan YatsynovichUmesh C SharmaPublished in: Diabetes & vascular disease research (2021)
Most of the trials discussed above demonstrate a survival advantage of CABG over PCI in patients with diabetes. However, recent advances in PCI technology are starting to challenge this narrative. Superior stent designs, use of specific drug-eluting stents, image-guided stent deployment, and the use of contemporary antiplatelet and lipid-lowering therapies are continuing to improve the PCI outcomes. Prospective data for such emerging interventional technologies in diabetes is however lacking currently and is the need of the hour.
Keyphrases
- coronary artery disease
- coronary artery bypass grafting
- percutaneous coronary intervention
- acute myocardial infarction
- st segment elevation myocardial infarction
- st elevation myocardial infarction
- antiplatelet therapy
- glycemic control
- acute coronary syndrome
- type diabetes
- coronary artery
- coronary artery bypass
- cardiovascular disease
- atrial fibrillation
- aortic stenosis
- electronic health record
- adipose tissue
- fatty acid
- heart failure
- metabolic syndrome
- artificial intelligence
- left ventricular